The aim of this study was to estimate the levels of circulating carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in subjects with gestational diabetes mellitus (GDM) and investigate the relationships between CEACAM1 and GDM. Circulating CEACAM1 levels were measured by ELISA kit in 70 women with GDM and 70 normal glucose tolerance (NGT) pregnant women. Blood samples were collected to detect fasting plasma glucose (FPG), fasting insulin (FINS) and glycosylated hemoglobin (HbA1c) levels in all participants. Insulin sensitivity index (ISOGTT) was calculated to assess insulin sensitivity.
Correlation analysis was performed between serum CEACAM1 levels and other parameters.Circulating CEACAM1 levels were higher in the GDM group than that in the NGT pregnant group, however, the difference showed no statistical significance (1889.82 ± 616.14 vs 1758.92 ± 433.15 pg/ml, p > 0.05). In GDM group, CEACAM1 was positively correlated with ISOGTT (R = 0.39, P = 0.001), while negatively with 1 h post-meal plasma insulin level (1hPINS) (R = -0.32, P = 0.008), 2 h post-meal plasma insulin level (2hPINS) (R = -0.33, P = 0.006) and area under curve of insulin (AUCI) (R = -0.36, P = 0.002) when adjusting for maternal age and gestational age.
The present study showed that circulating CEACAM1 levels did not differ in both GDM and NGT groups. However, we found a significant positively correlation between CEACAM1 and insulin sensitivity in the GDM group.
DACH1, a novel target of miR-218, participates in the regulation of cell viability, apoptosis, inflammatory response, and epithelial-mesenchymal transition process in renal tubule cells treated by high-glucose.
Objective: This report was designed to assess the functional role of miR-218/dachshund family transcription factor 1 (DACH1) in diabetic kidney disease (DKD) and investigate its possible molecular mechanism.Materials and Methods: From the GEO database, we downloaded different datasets for analyzing the expression of miR-218 and DACH1 in DKD. TargetScan was adopted to predict the binding sites between miR-218 and DACH1, which was further verified by dual-luciferase reporter assays. The renal proximal tubule cells (HK-2) treated with high glucose (HG) were used as an in vitro model.
QRT-PCR and western blot were used to determine the expression of DACH1 and other relative factors. Cell counting kit-8 and flow cytometer were applied to detect cell viability and apoptosis. The levels of inflammatory cytokines were determined by an ELISA assay.
NKG2D antibody (PE) |
MBS834175-01mg |
MyBiosource |
0.1mg |
EUR 700 |
NKG2D antibody (PE) |
MBS834175-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3010 |
Human NKG2D Antibody |
36795-05111 |
AssayPro |
150 ug |
EUR 215 |
CD314 (NKG2D) Antibody |
abx201090-01mg |
Abbexa |
0.1 mg |
EUR 477.6 |
|
NKG2D antibody (biotin) |
61R-1605 |
Fitzgerald |
100 ug |
EUR 458 |
|
Description: Armenian Hamster monoclonal NKG2D antibody (biotin) |
NKG2D antibody (biotin) |
MBS834983-01mg |
MyBiosource |
0.1mg |
EUR 765 |
NKG2D antibody (biotin) |
MBS834983-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3285 |
NKG2D antibody (allophycocyanin) |
61R-1778 |
Fitzgerald |
100 ug |
EUR 376 |
|
Description: Rat monoclonal NKG2D antibody (allophycocyanin) |
NKG2D antibody (allophycocyanin) |
MBS833721-005mg |
MyBiosource |
0.05mg |
EUR 640 |
NKG2D antibody (allophycocyanin) |
MBS833721-01mg |
MyBiosource |
0.1mg |
EUR 1030 |
NKG2D antibody (allophycocyanin) |
MBS833721-5x01mg |
MyBiosource |
5x0.1mg |
EUR 4475 |
CD314 (NKG2D) Antibody (PE) |
abx201092-100tests |
Abbexa |
100 tests |
EUR 927.6 |
|
CD314 (NKG2D) Antibody (APC) |
abx201093-100tests |
Abbexa |
100 tests |
EUR 828 |
|
CD314 (NKG2D) Antibody (FITC) |
abx201091-100tests |
Abbexa |
100 tests |
EUR 560.4 |
|
Anti-Mouse NKG2D Antibody |
103-M441 |
ReliaTech |
100 µg |
EUR 399 |
Description: NKG2D is a type II transmembrane protein with an extracellular C-type lectin domain. It occurs as a disulfide-linked homodimer that associates with either the DAP12 or DAP10 transmembrane adapter proteins. NKG2D is expressed on NK cells and some T cell subsets, where it functions as an activating receptor to trigger cytolytic activity and cytokine secretion. Ligands for human NKG2D include MICA, MICB, and ULBP-1, -2, -3, and -4. Mouse NKG2D ligands include H60, MULT-1, and Rae-1 alpha, beta, gamma, delta, and epsilon. |
Anti-Human NKG2D Antibody |
101-M585 |
ReliaTech |
100 µg |
EUR 399 |
Description: NKG2D is a type II transmembrane protein with an extracellular C-type lectin domain. It occurs as a disulfide-linked homodimer that associates with either the DAP12 or DAP10 transmembrane adapter proteins. NKG2D is expressed on NK cells and some T cell subsets, where it functions as an activating receptor to trigger cytolytic activity and cytokine secretion. Ligands for human NKG2D include MICA, MICB, and ULBP-1, -2, -3, and -4. Mouse NKG2D ligands include H60, MULT-1, and Rae-1 alpha, beta, gamma, delta, and epsilon. |
CD314 (NKG2D) Antibody (Biotin) |
abx201094-01mg |
Abbexa |
0.1 mg |
EUR 460.8 |
|
NKG2D Antibody HRP Conjugated |
MBS9460103-01mL |
MyBiosource |
0.1mL |
EUR 595 |
NKG2D Antibody HRP Conjugated |
MBS9460103-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2525 |
NKG2D Antibody FITC Conjugated |
MBS9460104-01mL |
MyBiosource |
0.1mL |
EUR 595 |
NKG2D Antibody FITC Conjugated |
MBS9460104-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2525 |
NKG2D Antibody FITC-Conjugated |
MBS542219-01mg |
MyBiosource |
0.1mg |
EUR 560 |
NKG2D Antibody FITC-Conjugated |
MBS542219-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2380 |
NKG2D Antibody Affinity Purified |
MBS540582-01mg |
MyBiosource |
0.1mg |
EUR 445 |
NKG2D Antibody Affinity Purified |
MBS540582-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1855 |
NKG2D Antibody BIOTIN-Conjugated |
MBS542218-01mg |
MyBiosource |
0.1mg |
EUR 560 |
NKG2D Antibody BIOTIN-Conjugated |
MBS542218-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2380 |
NKG2D Polyclonal Antibody |
MBS9237539-01mL |
MyBiosource |
0.1mL |
EUR 415 |
NKG2D Polyclonal Antibody |
MBS9237539-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1841 |
Anti-Mouse NKG2D Antibody (CX5) |
MBS1569793-01mg |
MyBiosource |
0.1mg |
EUR 405 |
Anti-Mouse NKG2D Antibody (CX5) |
MBS1569793-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1520 |
Human NKG2D Antibody (Biotin Conjugate) |
36795-05121 |
AssayPro |
150 ug |
EUR 315 |
NKG2D Antibody Antigenic Blocking Peptide |
MBS544043-025mg |
MyBiosource |
0.25mg |
EUR 280 |
NKG2D Antibody Antigenic Blocking Peptide |
MBS544043-5x025mg |
MyBiosource |
5x0.25mg |
EUR 1110 |
Anti-Mouse NKG2D Antibody (MI-6) |
MBS1569792-01mg |
MyBiosource |
0.1mg |
EUR 405 |
Anti-Mouse NKG2D Antibody (MI-6) |
MBS1569792-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1520 |
NKG2D Polyclonal Conjugated Antibody |
C46825 |
SAB |
100ul |
EUR 476.4 |
NKG2D Polyclonal Conjugated Antibody |
MBS9454723-01mLAF350 |
MyBiosource |
0.1mL(AF350) |
EUR 480 |
NKG2D Polyclonal Conjugated Antibody |
MBS9454723-01mLAF405 |
MyBiosource |
0.1mL(AF405) |
EUR 480 |
NKG2D Polyclonal Conjugated Antibody |
MBS9454723-01mLAF488 |
MyBiosource |
0.1mL(AF488) |
EUR 480 |
NKG2D Polyclonal Conjugated Antibody |
MBS9454723-01mLAF555 |
MyBiosource |
0.1mL(AF555) |
EUR 480 |
NKG2D Polyclonal Conjugated Antibody |
MBS9454723-01mLBiotin |
MyBiosource |
0.1mL(Biotin) |
EUR 480 |
NKG2D Antibody Western Blot Positive Control |
MBS542991-5Applications |
MyBiosource |
5Applications |
EUR 335 |
NKG2D Antibody Western Blot Positive Control |
MBS542991-5x5Applications |
MyBiosource |
5x5Applications |
EUR 1350 |
NKG2D Ligand 2 (ULBP2) Antibody |
abx005773-100g |
Abbexa |
100 µg |
EUR 175 |
NKG2D Ligand 2 (ULBP2) Antibody |
20-abx005773 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ul
- 50 ul
- 100 ul
- 200 ul
|
|
NKG2D Ligand 2 (ULBP2) Antibody |
abx029272-400l |
Abbexa |
400 µl |
EUR 518.75 |
NKG2D Ligand 2 (ULBP2) Antibody |
abx029272-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
NKG2D Ligand 2 (ULBP2) Antibody |
abx029272-80l |
Abbexa |
80 µl |
EUR 281.25 |
|
NKG2D Ligand 2 (ULBP2) Antibody |
20-abx142298 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
NKG2D Ligand 2 (ULBP2) Antibody |
abx320552-100l |
Abbexa |
100 µl |
EUR 350 |
NKG2D Ligand 2 (ULBP2) Antibody |
20-abx320552 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
NKG2D Ligand 2 (ULBP2) Antibody |
abx320552-50l |
Abbexa |
50 µl |
EUR 237.5 |
NKG2D Ligand 2 (ULBP2) Antibody |
abx239250-100l |
Abbexa |
100 µl |
Ask for price |
NKG2D Ligand 2 (ULBP2) Antibody |
abx239250-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
NKG2D Ligand 2 (ULBP2) Antibody |
abx239250-50l |
Abbexa |
50 µl |
EUR 350 |
Human CD314 (NKG2D) Monoclonal antibody |
314B-01MG |
ImmunoStep |
0,1 mg |
EUR 218.9 |
Rat Monoclonal anti-Mouse CD314 (NKG2D) Antibody |
xAP-0620 |
Angio Proteomie |
100ug |
EUR 280 |
NKG2D Polyclonal Antibody PE Conjugated |
MBS9462367-01mL |
MyBiosource |
0.1mL |
EUR 595 |
NKG2D Polyclonal Antibody PE Conjugated |
MBS9462367-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2525 |
Mouse Monoclonal anti-Human CD314 (NKG2D) Antibody |
xAP-0228 |
Angio Proteomie |
100ug |
EUR 280 |
NKG2D Polyclonal Antibody Bio Conjugated |
MBS9462366-01mL |
MyBiosource |
0.1mL |
EUR 595 |
NKG2D Polyclonal Antibody Bio Conjugated |
MBS9462366-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2525 |
NKG2-D Type II Integral Membrane Protein (NKG2D) Antibody |
abx430571-200l |
Abbexa |
200 µl |
EUR 387.5 |
NKG2-D Type II Integral Membrane Protein (NKG2D) Antibody |
abx430571-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
NKG2D |
E8ER1913-86 |
EnoGene |
100ul |
EUR 275 |
Description: Available in various conjugation types. |
NKG2D |
MBS8578073-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
NKG2D |
MBS8578073-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
NKG2D |
MBS8578073-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
NKG2D |
MBS8578073-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
Human NKG2D AssayLite™ Antibody (RPE Conjugate) |
36795-05151 |
AssayPro |
5 x 30 ug |
EUR 370 |
Human NKG2D AssayLite™ Antibody (APC Conjugate) |
36795-05161 |
AssayPro |
5 x 30 ug |
EUR 370 |
Human NKG2D AssayLite™ Antibody (FITC Conjugate) |
36795-05141 |
AssayPro |
2 x 75 ug |
EUR 370 |
Human NKG2D AssayLite™ Antibody (PerCP Conjugate) |
36795-05171 |
AssayPro |
5 x 30 ug |
EUR 410 |
CD314 (NKG2D) |
314A-100T |
ImmunoStep |
100 test |
EUR 730.8 |
CD314 (NKG2D) |
314F-100T |
ImmunoStep |
100 test |
EUR 450 |
CD314 (NKG2D) |
314PE-100T |
ImmunoStep |
100 test |
EUR 840 |
CD314 (NKG2D) |
314PU-01MG |
ImmunoStep |
0,1 mg |
EUR 356.4 |
CD314 (NKG2D) |
MO314PE(V50) |
ImmunoStep |
50 ug |
EUR 60 |
Mouse Anti-Human NKG2D monoclonal antibody, clone 2E22 |
CABT-L1930 |
Creative Diagnostics |
1 mg |
EUR 748.13 |
|
Description: Mouse |
NKG2D-IN-1 |
HY-155311 |
MedChemExpress |
Get quote |
Ask for price |
Description: NKG2D-IN-1 (compound 21) is a natural killer group 2D receptor (NKG2D) inhibitor with IC50s of 0.3 µM and 0.7 µM in NKG2D/MICA and ULBP6 TR-FRET assays, respectively[1]. |
NKG2D-IN-2 |
HY-155312 |
MedChemExpress |
Get quote |
Ask for price |
Description: NKG2D-IN-2 (compound 47) is a natural killer group 2D receptor (NKG2D) inhibitor with IC50s of 0.1 µM and 0.2 µM in NKG2D/MICA and ULBP6 TR-FRET assays, respectively[1]. |
NKG2D ligand 2 |
AP85547 |
SAB |
1mg |
EUR 2640 |
|
NKG2D Rabbit pAb |
E47R0938 |
EnoGene |
100ul |
EUR 295 |
NKG2D Rabbit pAb |
E47R21454 |
EnoGene |
100ul |
EUR 295 |
NKG2D Rabbit pAb |
E47R41364 |
EnoGene |
100ul |
EUR 295 |
Armenian Hamster Anti-Mouse NKG2D Monoclonal antibody, clone HMG2D |
CABT-L4409 |
Creative Diagnostics |
1 mg; 5 mg |
Ask for price |
|
Description: Armenian Hamster |
Armenian Hamster Anti-Mouse NKG2D Monoclonal antibody, clone HMG2D |
CABT-L4409-1mg |
Creative Diagnostics |
1 mg |
EUR 1076.4 |
Armenian Hamster Anti-Mouse NKG2D Monoclonal antibody, clone HMG2D |
CABT-L4409-5mg |
Creative Diagnostics |
5 mg |
EUR 2886 |
PE anti-mouse CD314 (NKG2D) |
E16FMP314-050U |
EnoGene |
50 μg |
EUR 433.33 |
Description: Available in various conjugation types. |
PE anti-mouse CD314 (NKG2D) |
E16FMP314-100U |
EnoGene |
100 μg |
EUR 866.67 |
Description: Available in various conjugation types. |
PE anti-mouse CD314 (NKG2D) |
E16FMP314-200U |
EnoGene |
200 μg |
EUR 1256.67 |
Description: Available in various conjugation types. |
PE anti-human CD314 (NKG2D) |
E16FHP314-025 |
EnoGene |
25 tests |
EUR 433.33 |
Description: Available in various conjugation types. |
PE anti-human CD314 (NKG2D) |
E16FHP314-100 |
EnoGene |
100 tests |
EUR 1256.67 |
Description: Available in various conjugation types. |
Anti-Human CD314 (NKG2D) PE |
MBS697097-100Tests |
MyBiosource |
100Tests |
EUR 450 |
Anti-Human CD314 (NKG2D) PE |
MBS697097-25Tests |
MyBiosource |
25Tests |
EUR 250 |
Anti-Human CD314 (NKG2D) PE |
MBS697097-5x100Tests |
MyBiosource |
5x100Tests |
EUR 1980 |
Anti-Mouse CD314 (NKG2D) PE |
MBS697098-005mg |
MyBiosource |
0.05mg |
EUR 235 |
Anti-Mouse CD314 (NKG2D) PE |
MBS697098-01mg |
MyBiosource |
0.1mg |
EUR 310 |
Anti-Mouse CD314 (NKG2D) PE |
MBS697098-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1355 |
APC anti-human CD314 (NKG2D) |
E16FHA314-025 |
EnoGene |
25 tests |
EUR 541.67 |
Description: Available in various conjugation types. |
APC anti-human CD314 (NKG2D) |
E16FHA314-100 |
EnoGene |
100 tests |
EUR 975 |
Description: Available in various conjugation types. |
APC anti-mouse CD314 (NKG2D) |
E16FMA314-025U |
EnoGene |
25 μg |
EUR 325 |
Description: Available in various conjugation types. |
APC anti-mouse CD314 (NKG2D) |
E16FMA314-050U |
EnoGene |
50 μg |
EUR 650 |
Description: Available in various conjugation types. |
APC anti-mouse CD314 (NKG2D) |
E16FMA314-100U |
EnoGene |
100 μg |
EUR 1126.67 |
Description: Available in various conjugation types. |
KLRK1/CD314/NKG2D Rabbit anti-Human Polyclonal (C-Terminus) Antibody |
MBS2402288-005mL |
MyBiosource |
0.05mL |
EUR 615 |
KLRK1/CD314/NKG2D Rabbit anti-Human Polyclonal (C-Terminus) Antibody |
MBS2402288-5x005mL |
MyBiosource |
5x0.05mL |
EUR 2605 |
FITC anti-mouse (CD314) NKG2D |
E16FMF314-050U |
EnoGene |
50 μg |
EUR 390 |
Description: Available in various conjugation types. |
FITC anti-human CD314 (NKG2D) |
E16FHF314-025 |
EnoGene |
25 tests |
EUR 498.33 |
Description: Available in various conjugation types. |
FITC anti-human CD314 (NKG2D) |
E16FHF314-100 |
EnoGene |
100 tests |
EUR 1061.67 |
Description: Available in various conjugation types. |
Biotin anti-human CD314 (NKG2D) |
E16FHB314-100U |
EnoGene |
100 μg |
EUR 780 |
Description: Available in various conjugation types. |
Biotin anti-mouse CD314 (NKG2D) |
E16FMB314-050U |
EnoGene |
50 μg |
EUR 346.67 |
Description: Available in various conjugation types. |
Biotin anti-mouse CD314 (NKG2D) |
E16FMB314-100U |
EnoGene |
100 μg |
EUR 693.33 |
Description: Available in various conjugation types. |
Purified anti-mouse CD314 (NKG2D) |
E16FMU314-500U |
EnoGene |
500 μg |
EUR 1083.33 |
Description: Available in various conjugation types. |
Purified anti-human CD314 (NKG2D) |
E16FHU314-100U |
EnoGene |
100 μg |
EUR 433.33 |
Description: Available in various conjugation types. |
PE-Cy7 anti-human CD314 (NKG2D) |
E16FHN314-025 |
EnoGene |
25 tests |
EUR 541.67 |
Description: Available in various conjugation types. |
PE-Cy7 anti-human CD314 (NKG2D) |
E16FHN314-100 |
EnoGene |
100 tests |
EUR 1148.33 |
Description: Available in various conjugation types. |
NKG2D / KLRK1 Immunizing Peptide |
MBS426409-01mg |
MyBiosource |
0.1mg |
EUR 225 |
NKG2D / CD314 Recombinant Protein |
11-223 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: NKG2D is a transmembrane protein belonging to the CD94/NKG2 family of C-type lectin-like receptors, also known as KLRK1, CD314, D12S2489E, KLR and killer cell lectin like receptor K1. NKG2D itself forms a homodimer whose ectodomains serve for ligand binding. NKG2D is a major recognition receptor for the detection and elimination of transformed and infected cells as its ligands are induced during cellular stress, either as a result of infection or genomic stress such as in cancer. In NK cells, NKG2D serves as an activating receptor, which itself is able to trigger cytotoxicity. The function of NKG2D on CD8+ T cells is to send co-stimulatory signals to activate them. |
NKG2D / CD314 Recombinant Protein |
11-282 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: NKG2D is a transmembrane protein belonging to the CD94/NKG2 family of C-type lectin-like receptors, also known as KLRK1, CD314, D12S2489E, KLR and killer cell lectin like receptor K1. NKG2D itself forms a homodimer whose ectodomains serve for ligand binding. NKG2D is a major recognition receptor for the detection and elimination of transformed and infected cells as its ligands are induced during cellular stress, either as a result of infection or genomic stress such as in cancer. In NK cells, NKG2D serves as an activating receptor, which itself is able to trigger cytotoxicity. The function of NKG2D on CD8+ T cells is to send co-stimulatory signals to activate them. |
NKG2D / CD314 Recombinant Protein |
11-299 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: NKG2D is a transmembrane protein belonging to the CD94/NKG2 family of C-type lectin-like receptors, also known as KLRK1, CD314, D12S2489E, KLR and killer cell lectin like receptor K1. NKG2D itself forms a homodimer whose ectodomains serve for ligand binding. NKG2D is a major recognition receptor for the detection and elimination of transformed and infected cells as its ligands are induced during cellular stress, either as a result of infection or genomic stress such as in cancer. In NK cells, NKG2D serves as an activating receptor, which itself is able to trigger cytotoxicity. The function of NKG2D on CD8+ T cells is to send co-stimulatory signals to activate them. |
Human NKG2D Recombinant Protein |
PROTP26718 |
BosterBio |
Regular: 20ug |
EUR 275 |
Description: Human NKG2D Recombinant Protein expressed in Baculovirus with hIgG-His-tag. Sequence domain: 73-216aa. Application(s): SDS-PAGE, Bioactivity. Endotoxin: < 1 EU per 1ug of protein (determined by LAL method). |
NE Purified anti-mouse CD314 (NKG2D) |
E16FMY314-500U |
EnoGene |
500 μg |
EUR 1126.67 |
Description: Available in various conjugation types. |
PerCP-Cy5.5 anti-human CD314 (NKG2D) |
E16FHS314-025 |
EnoGene |
25 tests |
EUR 498.33 |
Description: Available in various conjugation types. |
PerCP-Cy5.5 anti-human CD314 (NKG2D) |
E16FHS314-100 |
EnoGene |
100 tests |
EUR 1278.33 |
Description: Available in various conjugation types. |
NE Purified anti-human CD314 (NKG2D) |
E16FHY314-050U |
EnoGene |
50 μg |
EUR 498.33 |
Description: Available in various conjugation types. |
NE Purified anti-human CD314 (NKG2D) |
E16FHY314-500U |
EnoGene |
500 μg |
EUR 1061.67 |
Description: Available in various conjugation types. |
Human NKG2D / CD314, Fc Tag |
E24PHA192 |
EnoGene |
50 μg |
EUR 200 |
UNE Purified anti-human CD314 (NKG2D) |
E16FHZ314-1000U |
EnoGene |
1 mg |
EUR 2795 |
Description: Available in various conjugation types. |
NKG2D, Avi-Tag, Fc fusion |
100252 |
BPS Bioscience |
100 µg |
EUR 320 |
Description: Human NKG2d, also known as, Killer Cell Lectin Like Receptor K1, KLRK1, and NK Cell Receptor D. GenBank Accession No. NM_007360.4, a.a. 38-216, with an N-terminal Avi-Tag™ fused to the Fc portion of human IgG1 and expressed in a HEK293 cell expression system. MW=53 kDa. |
Human NKG2D / CD314, His Tag |
E24PHA193 |
EnoGene |
50 μg |
EUR 262 |
Human NKG2D Protein, mFc Tag |
E33P100079 |
EnoGene |
10 μg |
EUR 225 |
Mouse NKG2D Protein, hFc Tag |
MBS189277-001mg |
MyBiosource |
0.01mg |
EUR 260 |
Mouse NKG2D Protein, hFc Tag |
MBS189277-005mg |
MyBiosource |
0.05mg |
EUR 545 |
Mouse NKG2D Protein, hFc Tag |
MBS189277-5x005mg |
MyBiosource |
5x0.05mg |
EUR 2160 |
Human NKG2D Protein, mFc Tag |
MBS8575114-001mg |
MyBiosource |
0.01mg |
EUR 305 |
Human NKG2D Protein, mFc Tag |
MBS8575114-5x001mg |
MyBiosource |
5x0.01mg |
EUR 1220 |
Human NKG2D HEK293 Cell Line |
E24C00248 |
EnoGene |
each |
EUR 1225 |
Description: Human |
Mouse NKG2D HEK293 Cell Line |
E24C00250 |
EnoGene |
each |
EUR 1225 |
Description: Mouse |
Hamster monoclonal anti-mouse CD314 (NKG2D) |
gAP-0033 |
Angio Proteomie |
1mg |
EUR 450 |
Recombinant Mouse NKG2D/CD314 Protein |
RP02720 |
Abclonal |
1000μg |
EUR 219.64 |
|
Mouse CD3ζ&NKG2D EL4 Cell Line |
E24C00005 |
EnoGene |
each |
EUR 1225 |
Description: Mouse |
Human NKG2D&CD3ζ EL4 Cell Line |
E24C00010 |
EnoGene |
each |
EUR 1225 |
Description: Human |
Human NKG2D&CD3ζ EL4 Cell Line |
E24C00251 |
EnoGene |
each |
EUR 1225 |
Description: Human |
Human NKG2D&CD3ζ EL4 Cell Line |
E24C00252 |
EnoGene |
each |
EUR 1225 |
Description: Human |
Human NKG2D ligand 2 ELISA Kit |
EK4447 |
SAB |
96 tests |
EUR 599 |
|
Human NKG2D ligand 2 ELISA Kit |
MBS2880120-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 4080 |
Human NKG2D ligand 2 ELISA Kit |
MBS2880120-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 390 |
Human NKG2D ligand 2 ELISA Kit |
MBS2880120-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2220 |
Human NKG2D ligand 2 ELISA Kit |
MBS2880120-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 520 |
Human NKG2D ligand 2 ELISA Kit |
MBS761361-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3900 |
Human NKG2D ligand 2 ELISA Kit |
MBS761361-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 340 |
Human NKG2D ligand 2 ELISA Kit |
MBS761361-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2045 |
Human NKG2D ligand 2 ELISA Kit |
MBS761361-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 455 |
Human NKG2D ligand 2 ELISA Kit |
MBS9428273-5x96Tests |
MyBiosource |
5x96Tests |
EUR 2820 |
Results: A prominent raise of miR-218 was observed in DKD through bioinformatics analysis, which was further confirmed in the HG-induced model. DACH1 is a target of miR-218. miR-218 reduced cell viability and induced apoptosis by negatively regulating DACH1. Moreover, upregulating miR-218 in HG models increased the concentrations of pro-inflammatory cytokines TNF-α and IL-1β, reduced the level of anti-inflammatory cytokine IL-10, and promoted the epithelial-mesenchymal transition (EMT) process, which is possibly achieved by targeting DACH1.
While downregulating miR-218 showed the opposite results.Conclusion: These data demonstrated that, under an in vitro HG environment, miR-218 suppressed the HK-2 cells proliferation, promoted apoptosis, caused an inflammatory response, and facilitated the EMT process largely by targeting DACH1, providing an insight into the therapeutic intervention of DKD.